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ABSTRACT 
 
An Abstract of the Research Paper Of 
 
Anita Ihuwan, Bachelors of Science in Health Studies 
Title: Knowledge and Attitudes of College Students Concerning HIV/AIDS 
Professor: Dr. Misty Rhoads 
 
 The purpose of this study was to learn more about the knowledge and attitudes of college 
students concerning HIV/AIDS. Further investigation of this topic sought to provide insight into 
the perspective of college students. This study utilized a convenience sample of 25 students at a 
Midwestern university. Participants were administered questionnaires featuring questions 
concerning their knowledge and attitudes towards HIV/AIDS. Findings indicated that although 
the majority of participants believed they were well educated about HIV/AIDS, their response to 
knowledge questions showed otherwise. Findings also indicated that students would like to see 
more HIV programming on their campus. The implications of this study are important to health 
educators as they provide information, which may be utilized in the development of needs 
assessments and future HIV programming.  
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Chapter 1 
Literature Review 
Introduction 
The human immunodeficiency virus (HIV) is a chronic infection, which targets the 
immune system. This chronic condition can ultimately cause the infected individual to develop 
acquired immune deficiency syndrome (AIDS) (American Foundation for AIDS Research 
[amFAR], 2014). The virus depletes the body's CD4+ cells, a key element in the execution of 
proper immune response (Faith, O'Hehir, Malkovsky & Lamb, 1992). CD4+ cells are commonly 
referred to as T-Helper cells. Measured in cubic millimeters (mm3) of blood, CD4+ cells are 
abundant in a healthy body, hosting around 800-1200 cells/mm3 (Klimas, Koneru & Fletcher, 
2008). An individual infected with HIV experiences a depletion of CD4+ cells with the 
progression of the condition. Cold sores, warts, thrush and other minor infections occur with an 
absence of half of the body’s CD4+ cells. A diagnosis of AIDS occurs once the body has less 
than 200/mm3 of CD4+ cells (Klimas et al., 2008). At this point, an infected individual is 
susceptible to opportunistic infections that characterize AIDS. Opportunistic infections include, 
but are not limited to pneumocystis carinii, Kaposi's sarcoma, and toxoplasmosis (Klimas et al., 
2008). 
History 
Recognition of Immune Suppression 
 In 1981, The Centers for Disease Control and Prevention began investigating multiple 
cases of pneumocystis carinii among homosexual men in the Los Angeles area (Centers for 
disease Control and Prevention [CDC], 1981). These cases sparked an interest due to the nature 
of the disease. Pneumocystis carinii is a type of pneumonia that is typically diagnosed in 
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individuals with severely compromised immune systems, such as transplant recipients and 
chemotherapy patients (Jaffe, 2008). The interesting new trend continued to occur as more 
homosexual men in San Francisco and New York were diagnosed with this rare form of 
pneumonia. Health officials also began to see cases of Kaposi's sarcoma, a rare cancer that is 
typified by large purple lesions, which appear on the skin. With two opportunistic diseases 
effecting homosexual men with no illnesses known to cause immune suppression, the CDC 
began a rigorous search to find the cause of these diseases (Jaffe, 2008).   
 Evidence that the mysterious disease was transmissible through sexual contact occurred 
when a case study showed that most of the effected patients had numerous sexual partners (Jaffe, 
2008). In 1982, the link was made to sexual contact after examination of a case study showed 
that many patients had prior sexual contact with each other (Jaffe, 2008). Further research found 
that a French Canadian flight attendant who was diagnosed with Kaposi's sarcoma had sexual 
contact with four men in California as well as New York. These partners went on to develop 
various opportunistic infections (Jaffe, 2008).  
Infection in the Blood Supply 
 At the summer's end of 1982, an older man with hemophilia was reported to have died 
due to an infection of pneumocystis carinii (CDC, 1982). Subsequently, two more deaths 
occurred in hemophiliacs who developed the pneumonia. The development of opportunistic 
infection in heterosexual hemophiliacs caused researchers to look into different modes of 
transmission (Jaffe, 2008).  Healthcare providers also observed the rising rate of opportunistic 
infections among infants who recently received blood transfusions.  
 By 1983, researchers gathered enough evidence to conclude that AIDS could be 
transmitted through blood as well as the blood products given to hemophiliacs. The presentation 
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of this information to the Food and Drug Administration (FDA), the National Hemophilia 
Foundation and various blood banks was unsuccessful. A meeting held in January 1983 was 
called to discuss the matter. The researchers working on the AIDS epidemic found that the 
hepatitis b antibody test could be used to reduce the existence and acquisition of contaminated 
blood (Jaffe, 2008). The execution of this testing did not occur until much later. By the end of 
1983, 2,807 cases of AIDS had been reported and the nation's death toll was 2,118 (amFAR, 
1983). 
Today 
  Thirty-five million people have died of AIDS-related complications since the beginning 
of the epidemic (World Health Organization [WHO], 2014). Since the discovery of HIV/AIDS, 
scientists have been able to greatly extend the life expectancy of patients. Along with great 
success is the need for further development. An estimate by the Central Intelligence Agency 
reported that in 2009 there were 1.2 million people living with HIV/AIDS in the United States. 
That estimate ranks the nation among the top ten countries with the highest population of 
HIV/AIDS positive residents. South Africa ranks first with an estimated 5.6 million cases 
(Central Intelligence Agency, 2009).   
Transmission 
 The transmission of HIV occurs through exposure to infected breast milk, blood, semen, 
and vaginal fluids (Moss, 2013). Infection can occur once an uninfected individual is exposed to 
the virus via mucous membranes as well as the blood stream. Moreover, HIV is transmissible 
through sexual intercourse, intravenous drug use, blood and blood products, and from mother to 
child in utero as well as the consumption of HIV positive breast-milk (Moss, 2013). Infections 
via blood transfusions have significantly declined through HIV testing but not eradicated. 
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Blood Transfusions   
 The use of nucleic acid testing (NAT) has greatly reduced the rate of transmission of HIV 
from blood transfusions. Prior to the use of NAT, the rate of transmission amongst recurring 
blood donors ranged from 1 in 450,000 to 660,000. The rate has dropped to 1 in 2,135,000 since 
the implementation of NAT (Phelps et al., 2004). In first time donors the rate of transmission is 1 
in 1.2 million to 1.8 million. NAT has also reduced the window period to ten to fifteen days. The 
window period is characterized by HIV antibodies present in a newly infected individual, though 
the virus is able to remain undetected (WHO, 2013b). 
 In July 2002, the CDC and the FDA were notified of an HIV positive blood donor. The 
donor, an 18 year old female high school student began donating blood on September 12th 2001, 
in response to the recent terrorist attacks. After reviewing her blood donation history, the 
agencies learned that she had donated blood in March 2002 (Phelps et al., 2004). Two people 
received blood from the March donation and subsequently tested positive for HIV. Upon initial 
donation, the blood was tested for HIV and the results came back negative. Through extensive 
research, the CDC determined that the donor unknowingly acquired HIV and donated blood 
within the ten day period of detection (Phelps et al., 2004). 
Sexual Transmission 
 The acquisition of HIV via sexual exposure is dependent on the number of sexual 
contacts with HIV positive individuals as well as the viral load of the positive individuals (Moss, 
2013). Furthermore, the possibility of contracting HIV is higher among those with sexually 
transmitted infections (STIs). Partners with genital ulcers experience a risk of infection 300 times 
greater than those without ulcers. Transmission is significantly higher in individuals with genital 
ulcers because of the lacerations caused by the ulcers (Kalichman, Pellowski, & Turner, 2011). 
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Individuals with STIs such as genital herpes and syphilis that contract HIV have an abundance of 
HIV antibodies in their genital fluid. Although the risk of HIV transmission via oral sex is low, 
lacerations in the mouth increase the chance of infection (Kalichman et al., 2011).  
 Upon exposure to HIV by sexual intercourse, the virus attacks the body's CD4+ CCR5+ T 
cells that are found in the genital and rectal mucous membrane (Gasper-Smith et al., 2011). After 
a period of localization that lasts approximately ten days, the virus spreads by way of blood 
through the lymphoid tissue. In a span of three to four weeks, the viral load of the individual with 
HIV rises to millions of virus per millimeter of plasma (Fieberg, 2003). Sexual transmission 
accounts for 90% of all HIV infections (CDC, 2014c). The risk of sexual transmission can be 
significantly reduced through the practice of abstinence as well as the use of condoms (amFAR, 
2014).   
Worldwide 
 Although most transmissions of HIV occur through sexual intercourse, different modes of 
transmission are more prevalent worldwide (Moss, 2013). Eastern European countries as well as 
eastern and southeastern Asian countries have high rates of HIV transmission because of 
intravenous drug use. Forty percent of intravenous drug users in Eastern Europe and eastern and 
southeastern Asia are HIV positive (United Nations Office on Drugs and Crime [UNODC], 
2010). Intravenous drug users experience a high risk of acquisition because the needles used are 
unsterilized, thereby exposing users to a variety of blood-borne pathogens (Moss, 2013). The risk 
of transmission is three times higher through shared needles than through sexual intercourse 
(UNODC, 2010). 
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Stages of infection 
According to the CDC, HIV occurs in three stages: acute infection, clinical latency, and 
AIDS (AIDS.gov, 2013; CDC, 2014a). Contrary to the CDC, the WHO acknowledges four 
stages of HIV. The four stages are: the primary infection, the clinically asymptomatic stage, the 
symptomatic HIV infection, and the progression from HIV to AIDS (WHO, 2007). Although 
both classification systems acknowledge a primary infection, the system used by the WHO relies 
on clinical symptoms. The prioritization of symptoms rather than CD4+ counts allows 
practitioners from various professional backgrounds to provide care and assistance to HIV 
positive individuals (U.S. Department of Human Health and Services, 2011). 
Primary Infection 
 The primary infection occurs two to four weeks after the individual has been exposed to 
HIV. In this stage, the host experiences flu-like symptoms and swollen lymph nodes. Inside the 
host, an immune response occurs as a result of the virus in the peripheral blood. This process, 
characterized by the production of HIV antibodies and cytotoxic lymphocytes, is called 
seroconversion (AVERT, 2014).    
Asymptomatic 
 The asymptomatic stage can last up to ten years.  Although referred to as asymptomatic, 
the HIV infection causes a variety of symptoms regardless of the host's CD4+ count. Moreover, 
the referral to this stage as asymptomatic is incorrect (Willard et al., 2009). In reference to the 
absence of opportunistic infections, the referral to the stage as asymptomatic ignores day to day 
symptoms experienced by HIV positive individuals. Willard et al. (2009) studied the symptoms 
experienced by HIV positive individuals. Over 50% of participants clinically categorized as 
asymptomatic reported symptoms of depression, muscle ache, weakness, and thirst. Symptoms 
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were experienced regardless of the use of antiretroviral drugs. According to Willard et al.,“It is 
important for HIV clinical practice guidelines to reflect the fact that HIV-positive people may 
experience symptoms throughout their disease, and that these must be managed to improve 
quality of life” (p. 327). 
Symptomatic HIV Infection 
 As HIV progression continues the immune system becomes severely compromised by the 
virus. The deterioration of the immune system is a result of various issues occurring in the body 
(Avert, 2014). As the virus mutates, it becomes more pathogenic, causing further destruction to 
the CD4+ cells. If the body cannot replace the lost CD4+ cells, HIV becomes symptomatic. The 
symptomatic HIV infection is typified by illness affecting all systems of the body (Avert, 2014). 
HIV positive individuals may experience severe weight loss—10% or more of their body weight. 
Other symptoms include, but are not limited to: persistent oral candidiasis—a yeast infection on 
the mucosa of the mouth, gingivitis, and periodontitis (WHO, 2007). 
Progression from HIV to AIDS 
 Further deterioration of the immune system leads to the development of opportunistic 
infections (Avert, 2014). According to Schneider et al. (2008), a diagnosis of AIDS requires a 
CD4+ cell count less than 200 cells/mm3 or the documentation of one of the 26 AIDS defining 
opportunistic infections. AIDS defining opportunistic infections include HIV encephalopathy, 
toxoplasmosis of the brain, and HIV wasting syndrome (CDC, 2008). HIV encephalopathy is a 
neuro-cognitive condition which causes destruction of the brain tissue (Schlote, 1991; WHO, 
2007). HIV encephalopathy leaves the individual with cognitive and motor dysfunctions. 
Cerebral toxoplasmosis is a neurologic infection caused by a parasite found in raw and 
undercooked meat (Colombo et al., 2005). The condition can cause encephalitis, which is the 
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inflammation of the brain. HIV wasting syndrome causes the individual to experience extreme 
weight loss greater than 10% of the body weight in conjunction with chronic diarrhea lasting 
longer than one month (WHO, 2007). 
Diagnosis 
 HIV testing is divided into two categories, screening and confirmatory tests. Initially 
individuals receive screening tests. If a positive test result occurs a subsequent confirmatory test 
is given. Screening tests include enzyme-linked immunosorbent assays (ELISA) and rapid 
antibody tests (Marquez, Zetola, & Klausner, 2008). Screening tests result in minimal false 
negative results due to the high sensitivity of antibody testing. Confirmatory tests such as the 
Western Blot have a low probability of false positive due to the high specificity of the test 
(Marquez et al., 2008). 
Screening Tests  
 ELISA testing detects the presence of HIV antibodies in oral fluid, blood, and urine 
(University of California San Francisco [UCSF], 2011). ELISA functions through the use of a 
micro-well plate (Marquez et al., 2008). Coated with an HIV antigen, a sample of the specimen 
is placed to detect the existence of HIV antibodies. Through a process of multiple washings and 
mathematical calculations, the antibody status in the specimen is determined. Results can take up 
to two weeks to be found (UCSF, 2011). 
 Rapid antibody tests also use oral fluid, urine and blood to detect the presence of HIV 
antibodies. Rapid antibody testing differs from ELISA in the time from testing to the 
determination of test results. Rapid testing yields results in less than 20 minutes (AIDS.gov, 
2012b). Testing can be administered in clinical settings such as hospitals and doctors’ offices or 
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in the privacy of a home (Marquez et al., 2008). OraQuick Advance, an over the counter oral 
rapid test, allows individuals to perform HIV testing without assistance (Irarrazábal et. al., 2013).  
 Irarrazábal et al. (2013) compared the specificity of ELISA and oral rapid testing. Of 497 
participants, 37% yielded positive results through the use of ELISA. The oral rapid test found 
36.4% of participants “reactive” for HIV. Three hundred and forty-four participants were 
unaware of their HIV status at the start of the study. Of the 344 people, 55 did not return to 
receive their ELISA results. Furthermore, participants preferred the oral rapid testing because of 
the reduced waiting time and experienced less anxiety (Irarrazábal et. al., 2013). 
Confirmatory Testing 
 Positive HIV tests need to be confirmed though the use of confirmatory tests such as the 
Western Blot. More time consuming and expensive, the Western Blot identifies HIV proteins in 
the specimen. The proteins are divided and transferred onto nitrocellulose paper. The specimen 
being tested is added to the paper. If HIV antibodies are present, a binding of antibodies and 
corresponding antigens occurs (Marquez et al., 2008). CDC (2007) guidelines state 
(a) Positive test result is defined by the presence of any two of the following 
bands:  p24, gp41, and gp120/160. (b) An indeterminate result is defined as bands 
present that do not meet the criteria for positive. (c) A negative result is defined as 
no bands present. (p. 21) 
Treatment 
 HIV is treated with the use of highly active antiretroviral therapy (HAART). HAART 
works through the use of multiple medicines, to minimize the presence of the virus in the blood. 
WHO (2013a) guidelines dictate that the initiation of HAART is recommended in HIV positive 
adults and adolescents with CD4+ counts greater than 350 cells/mm3 and less than or equal to 
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500 cells/mm3. It is also recommended than HAART is initiated regardless of CD4+ count if the 
HIV positive individual has active tuberculosis, hepatitis b with chronic liver disease or is in a 
relationship with an HIV negative individual (WHO, 2013a). Relationships in which partners 
have different HIV statuses are referred to as serodiscordant (AIDS.gov, 2012a). Although 
HAART is not a cure for HIV, the regimen has turned HIV from a terminal illness to a chronic 
condition (Stebbing, Bower, Mandalia, Nelson, & Gazzard, 2006).  
HAART 
 HAART works effectively through the use of combination drug therapy (Stebbing et al., 
2006). Though treatments are specialized for each patient, the standard therapeutic combination 
includes two nucleoside reverse-transcriptase inhibitors (NRTIs) and either a protease inhibitor 
or a non-nucleoside reverse-transcriptase inhibitor (NNRTI). The utilization of a minimum of 
three medicines is necessary to reduce the possibility of developing drug resistance. HAART has 
decreased the mortality and morbidity of patients by reducing the incidence of opportunistic 
infections. HAART also works to increase the body's CD4+ count (Stebbing et al., 2006). Though 
combination drug therapy has been proven to be successful in the treatment of HIV, side effects 
of the medication greatly impact patients. 
Adherence to HAART 
 Although HAART serves to help the lives of individuals with HIV, side effects due to the 
treatment cause adherence issues in users. Johnson and Folkman (2004) studied the symptomatic 
side effects of HAART in HIV positive individuals. Forty-three percent of participants reported 
missing a dosage of HAART due to side effect related reasons. Side effects experienced by 
participants include: diarrhea, neuropathy, nausea, vomiting, and fatigue (Johnson & Folkman, 
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2004). In order to cope with the symptoms of HIV and the side effects of HAART, cannabis has 
been used by some HIV positive individuals (Bonn-Miller, Oser, Bucossi, & Trafton, 2014). 
 Bonn-Miller et al. (2014) studied the adherence to HAART in cannabis users. One 
hundred and eighty participants were divided into three groups: cannabis dependent users, non-
cannabis users, and nondependent cannabis users. Cannabis dependent users were found to have 
low regimen adherence to HAART and lower CD4+ counts than non-cannabis users and 
nondependent cannabis users. Cannabis failed to alleviate the side effects and symptoms 
experienced by participants. Cannabis dependent users experienced stronger symptoms of HIV 
and side effects of HAART (Bonn-Miller et al., 2014).  
Cost of Care  
 The cost of treatment for HIV positive individuals increases with the progression of the 
virus and further immune suppression (Gebo et al., 2010). Per year, HAART costs upwards of 
$10,000. Patients with CD4+ counts less than 50 cells/mm3 experience high inpatient treatment 
costs and lower costs for HAART. Due to the immune suppression and resistance to many 
HAART medications, in-patient treatment becomes a necessity. Gebo et al. (2010) determined 
the cost of care for individuals with CD4+ counts less than 50 cells/mm3 to be significantly 
higher than individuals with less immune suppression. In three US sites, medical expenses for 
one year ranged from $33,566 to $47,789 for individuals with CD4+ counts less than 50 
cells/mm3. In contrast, individuals with CD4+ counts greater than 500 cells/mm3 experienced 
care costs of $16,502 to $17,177 (Gebo et al., 2010).   
HIV in the Youth  
Prevalence  
 Youth in the United States aged 13 to 24 accounts for a significant amount of new HIV 
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infections. In 2010, an estimated 26% of all new HIV infections occurred in the nation’s youth. 
Of an estimated 10,456 HIV diagnoses among the youth, 78% of the diagnoses occurred in 
people between the ages of 20 and 24. The prevalence of HIV in the youth is largely due to the 
lack of adherence to preventative measures, participation in risky behaviors, and low testing rates 
(CDC, 2014b).  
Knowledge of the Virus 
 Although college aged students are educated about HIV, rates of infection remain high 
(CDC, 2014b). Partly due to misconceptions about transmission and symptoms, many HIV 
transmissions occur during primary infection stage. Up to 50% of all new HIV transmissions are 
the result of exposure to HIV during the primary infection (Brenner et al., 2007). 
 Grin, Chan, and Operario (2013) studied the knowledge of the primary infection among 
homosexual and bisexual male students from Ivy League universities. Participating students aged 
from 18 to 25, with an average age of 20.4 years. Of the 100 surveyed students, 77% had 
previously taken HIV tests and 15% had been treated for STIs. Fifty-five percent of students 
believed HIV transmissibility was low immediately after infection. Also, 44% of students failed 
to acknowledge the overall transmissibility and production of HIV antibodies in the primary 
infection. Though general knowledge about HIV was known by most students, misconceptions 
about transmission confirmed the importance of further education among students (Grin et al., 
2013). 
Sexual Risk Behaviors  
 Adefuye, Abiona, Balogun, and Lukobo-Durrell (2009) investigated the HIV risk 
behaviors among college students in the Midwest. Participants of the study included 390 students 
from various ethnic backgrounds. Eighty-seven percent of students were reported to be sexually 
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experienced. Of the sexually experienced students, 27.1% became sexually active by the age of 
14.When asked about current sexual practices, many reported recent sexual contact with multiple 
partners and inconsistent condom use. Students who participated in illicit drug use and alcohol 
consumption were found to have a high likelihood of having two or more sexual partners in 30 
days. Though participants understood the effects of engaging in high risk behaviors, the fear of 
exposure to HIV was low. Adefuye et al. argued the necessity of media to create further 
awareness and encourage preventative measures. 
Summary 
 Although tremendous advancements have been made in HIV/AIDS research since the 
emergence of HIV/AIDS in 1981, 35 million lives have been lost (WHO, 2014). The 
development of highly active antiretroviral therapy has brought hope to people affected by HIV, 
extending lives by slowing the progression of the virus (Stebbing et al., 2006). Even through 
such great success, preventative measures such as the use of condoms and the practice of 
abstinence are most effective in ending the epidemic (amFAR, 2014). Prevention and education 
need to be further conveyed to the youth in order eradicate HIV/AIDS (Adefuye et al., 2009). 
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Chapter 2 
Methods 
Introduction 
The purpose of this study was to explore the knowledge and attitudes of college students 
concerning HIV/AIDS. This descriptive study sought to determine if prior education on HIV 
affected attitudes toward HIV/AIDS. 
Research Design 
Participants 
 The participants consisted of 25 students from a mid-sized Midwestern University. 
Participants were male and female aged between 20 and 25 years. Participation in the study was 
completely voluntary and no an academic credit was given. Participants were from varying 
academic classes ranging from sophomore to senior. 
Research Question 
What are college student’s attitudes and knowledge about HIV/AIDS? 
Research Instrumentation 
A 20-question questionnaire was administered in which face and content validity was 
established. The questionnaire covered the demographic backgrounds of the participants as well 
as knowledge and attitudes about HIV/AIDS. The survey consisted of multiple choice and Likert 
scale questions.  
Data Collection 
 The data was acquired through a convenience sample taken from a mid-size Midwestern 
University. Participants were aged between 20 and 25 years. Consent was obtained from a signed 
and dated consent form (Appendix C). Consent forms will remain in the professor’s office for 
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five years. Data collection occurred during a one-week period. At the end of the data collection 
period, the data was analyzed using Microsoft Excel.  
Data Analysis 
 Data analysis occurred using Microsoft Excel. Data was reported by the use of 
frequencies and percentages. Descriptive statistics allowed the researcher to better understand the 
knowledge and attitudes of college students concerning HIV/AIDS. 
Summary 
 The purpose of this study was to explore the knowledge and attitudes of college students 
concerning HIV/AIDS and to gain a better understanding if knowledge affected attitudes. This 
was a descriptive study that was non-experimental and utilized a convenience sample. A 20-
question questionnaire was used featuring content and face validity. The data was reported and 
analyzed through Microsoft Excel to evaluate frequencies and percentages.  
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CHAPTER 3 
RESULTS 
 Through the use of a convenience sample, 25 students were administered questionnaires 
featuring questions concerning knowledge and attitudes concerning HIV. College students were 
selected as the sample population due to high rates of sexually transmitted infections. Further, 
among young people there is a low perception of risk for contracting HIV. Thus, understanding 
the attitudes of college students toward HIV as well as their knowledge of the topic is 
fundamental to the development of future intervention strategies. 
Sample Demographics 
 The convenience sample consisted of 25 participants in the fall of 2014. Participants were 
24% male (N=6) and 76% female (N= 19). Ages of participants ranged from 20 to 25 years old. 
Of participants, 92% were between the ages of 20 and 22 years (N= 23), and 8% were between 
the ages of 23 and 25 years (N=2). The majority of participants were seniors 68% (N=17), 
followed by juniors 28% (N=7), and sophomores 4% (N=1). Participants were from varying 
ethnic backgrounds. Of respondents, 44% (N=11) were Caucasian, 26% (N=9) were African 
American, 8% (N= 2) were Hispanic, and 12% (N=3) were from two or more ethnic 
backgrounds.  
Research Question 
What are the attitudes and knowledge of college students concerning HIV? 
Findings 
Knowledge 
 Participants were asked what the acronym HIV stands for. Eight percent (N=2) answered 
“Human Immunoinsufficiency Virus”, 4% (N=1) answered “Human Immunocompromisation 
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Virus”, and 88% (N=22) correctly answered “Human Immunodeficiency Virus”. When asked the 
modes which HIV is transmitted, 8.3% (N=2) indicated HIV was not transmissible through 
semen, 20.8% (N=5) indicated HIV was not transmissible through breast milk, and 70.8% 
(N=17) indicated HIV was not transmissible through saliva. Participants were asked the length 
which the asymptomatic stage of HIV lasts, 36% (N=9) responded 1 year, 44% (N=11) 3 years, 
16% (N=4) 10 years, and 4% (N=1) 15 years. When asked how HIV is typically diagnosed, 8% 
(N=2) answered MRI, 4% (N=1) answered X-Ray, 80% (N=20) answered oral fluid swab, and 
8% (N=2) answered lung biopsy. Participants were asked how many people are HIV positive 
worldwide. Twenty-four percent (N=6) responded 2 million people are HIV positive, 48% 
(N=12) responded 10 million, and 28% (N=7) responded 25 million people. Zero participants 
correctly answered the question, which is 35 million people (See Graph 1).  
Graph 1 
Response to: how many people are HIV positive worldwide? 
  
When asked the difference between HIV and AIDS, 8% (N=2) answered there is no difference 
between HIV and AIDS, 92% (N=23) answered HIV causes AIDS, and zero participants 
answered AIDS only occurs to poor people. Participants were asked the method which HIV is 
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treated. Zero participants responded dialysis nor radiation, 56% (N=14) responded combination 
drug therapy, and 44% (N=11) responded that there is no treatment available (See graph 2).  
Graph 2 
Response to: how HIV is treated? 
 
When asked to respond to the statement “If a person is exposed to HIV on a Saturday, the virus 
can be transmitted by the following Saturday”, Zero participants strongly disagreed, 25% (N=6) 
disagreed, 70.8% (N=17) agreed, and 4.2% (N=1) strongly agreed. 
Attitudes 
 Participants were asked if they believed they were well educated about HIV. Zero 
participants strongly disagreed with the statement, 32% (N=8) disagreed, 56% (N=14) agreed, 
and 12% (N=3) strongly agreed with the statement. When asked if nothing can be done once 
exposed to HIV, 8% (N=2) strongly disagreed, 44% (N=11) disagreed, 44% (N=11) agreed, and 
4% (N=1) strongly agreed. When asked to respond to the statement “It is unlikely to contract 
HIV while in college”, 48% (N=12) strongly disagreed, 44% (N=11) disagreed, 8% (N=2) 
agreed and zero participants disagreed. When participants were asked if they could identify an 
HIV positive individual by looking at them, 80% (N=20) strongly disagreed, and 20% (N=5) 
disagreed. Participants were asked if they believed there were enough HIV awareness programs 
on their college campus. Twenty-four percent (N=6) strongly disagreed that there were enough 
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HIV awareness programs, 64% (N=16) disagreed, and 12% (N=3) agreed to the statement. Zero 
participants strongly agreed that there were enough HIV awareness programs on their college 
campus (See Chart 1). 
Chart 1 
Response to: are there enough HIV awareness programs on your campus? 
 
When asked if HIV affects individuals from all social, economic, and ethnic backgrounds, 4% 
(N=1) disagreed, 64% (N=16) agreed, and 32% (N=8) strongly agreed. Participants were asked if 
they believed HIV testing should be free and readily available to college students. Sixty percent 
(N=15) strongly agreed, 32% (N=8) agreed, and 8% (N=2) disagreed (See Chart 2). 
Chart 2 
Belief that HIV testing should be free for college students 
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When asked if participants believed if HIV positive individuals are to blame for their infection, 
36% (N=9) strongly disagreed, 52% (N=13) disagreed, 8% (N=2) agreed, and 4% (N=1) strongly 
agreed. 
Summary 
 Although 68% of participants believed that they were well educated about HIV, survey 
results dictated otherwise. No respondents were able to correctly identify the global prevalence 
of HIV thereby indicating sample participants do not understand the scope of the health issue. 
Furthermore, 44% of sample participants believed there is no treatment available for HIV. It is 
evident that there is a need for additional HIV awareness program. This conclusion is further 
validated by 88% of respondents, who do not believe there are enough HIV awareness programs 
on their campuses.  
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CHAPTER 4 
SUMMARY, CONCLUSIONS, DISCUSSION AND RECOMMENDATIONS 
Conclusions 
Upon reviewing the data from the study, the following conclusions were made:  
1.) College students do not recognize the prevalence of the HIV/AIDS, therefore do not 
understand the scope of the epidemic. According to the study, zero participants were 
aware that there are 35 million HIV/AIDS positive individuals worldwide. 
2.) The majority of college students would like to see more HIV awareness programs on 
their campus. According to the study, 88% of participants indicated that there were not 
enough HIV awareness programs on their campus. 
3.) A majority of college students believe HIV testing should be free. According to the study, 
92% of participants believe HIV testing should be free on their campus. 
Discussion 
 
According to a CDC 2010 estimate, youth aged 13-24 account for 26% of all HIV 
infections. Further, of the 10,456 estimated infections in this age group, 78% of infections 
occurred among 20-24 year olds. The high prevalence of HIV among this population is due to 
low testing rates, minimal perceived risk, and participation in risky behaviors (CDC, 2014b). 
While college students received education on HIV/AIDS prevention, they remain susceptible to 
HIV exposure.  
In this study, the knowledge and attitudes of college student concerning HIV/AIDS was 
examined on a Midwestern University campus. Findings indicated that although the majority of 
participants believed they were well educated about HIV/AIDS, their response to knowledge 
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questions showed otherwise. Findings also indicated that students would like to see more HIV 
programming on their campus.  
While HIV/AIDS affects 35 million people worldwide, the prevalence of the virus was 
grossly underestimated by college students (WHO, 2014). Recognizing the prevalence of 
HIV/AIDS is essential to fathom the scope of the global epidemic. This error in judgment 
correlates to the low perceived risk of HIV exposure among college students. According to the 
study, 24% of respondents thought there were 2 million HIV/AIDS positive individuals globally. 
This misconceptions indicated that college student do not perceive the risk of HIV exposure 
because they undervalue the prevalence of the virus.  
To rectify the present misconceptions in HIV education, further programming is 
necessary on college campuses. Although most college students have received prior HIV 
education, students may benefit from recurring education. While the majority of participants 
indicated that they had received prior HIV education, an even greater percent of respondents 
indicated there were not enough HIV awareness programs on their campus. With the growing 
emergence of technology, it may be beneficial to develop awareness programming which appeals 
directly to this population. Rather than education, which focuses solely on facts, HIV programs 
for college students should seek to make students more aware of risks and prevention measures.  
Introducing a program that offers HIV testing on college campuses may also reduce the 
prevalence of HIV on college campuses. According to the CDC, lower rates of HIV testing are 
common among those ages 20-24 years (CDC, 2014b). Respondents of this study indicated that 
HIV testing should be free and readily available to college students. Although this may not be 
feasible for all college campuses, sponsoring an annual event offering free HIV testing may be a 
practical compromise.  
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While youth aged 20-24 accounts for 78% of all HIV infections among youth, through 
the use of targeted health promotion the prevalence of HIV in the group will be reduced (CDC, 
2014b). Further, although college students have prior HIV education, misconceptions still 
remain. Utilizing technology as a platform for information dissemination will allow health 
educators to reach populations more rapidly and with greater ease.   
Limitations of the Study 
 These findings are subject to several limitations due to the methods used to obtain them. 
The questionnaire was administered utilizing convenience sampling in a single location; 
therefore results are not indicative of all college students. The results were obtained from a 
sample of 25 students—therefore—results are not statistically significant. Additionally, the 
sample did not include participants from all academic classes, thereby making any 
generalizations about college students questionable. 
Recommendations for Future Research 
 
When conducting future research the knowledge and attitudes of college students 
concerning HIV, it would be beneficial for the researcher to:   
1.) Use a larger and more representative sample of college student participants. 
2.) Use a simple random sample. 
3.) Incorporate questions addressing stigmas. 
Recommendations for Health Educators 
 
1.) Through the use of programming which addresses HIV on a global scale and its 
implications to various populations, college students may begin to perceive the risk of 
HIV exposure. This perception of risk may inspire behavior change. 
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2.) By developing further HIV awareness programs on college campuses, students will have 
the opportunity to better educate themselves about HIV. Through education students will 
more aware of the virus as well as strategies to protect themselves for HIV exposure. 
3.) With the incorporation of free HIV testing, college students will able to receive HIV 
without concern of the financial burden. This action may increase the rate of HIV testing 
among this population and in turn reduce rates of transmission. 
Summary 
 
 Since the discovery of HIV in 1981, 35 million people have died due to AIDS-related 
complications (WHO, 2014). Although modern medical science has evolved HIV from a 
terminal illness to a chronic managed condition, the HIV epidemic is a cause for concern. While 
there are 35 million people living with HIV/AIDS worldwide, HIV affects the nation’s youth at 
an alarming rate. The purpose of this study was to explore the knowledge and attitudes of college 
students concerning HIV/AIDS. Results indicate that further attention concerning HIV and 
college students is necessary. The implications of this study are important to health educators as 
they provide information, which may be utilized in the development of needs assessments and 
future HIV programming. In addition, it may be beneficial for college campuses to establish free  
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Appendix A 
Definitions 
 
AIDS-Defining Disease: “A disease which, when accompanied by evidence of HIV infection, 
fulfills the criteria necessary to diagnose AIDS” (Segen's Medical Dictionary, 2012) 
 
1. “Candidiasis of bronchi, trachea, or lungs 
2. Candidiasis of esophagus 
3. Cervical cancer, invasive 
4. Coccidioidomycosis, disseminated or extrapulmonary 
5. Cryptococcosis, extrapulmonary 
6. Cryptosporidiosis, chronic intestinal (>1 month's duration) 
7. Cytomegalovirus disease (other than liver, spleen, or nodes), onset at age >1 month 
8. Cytomegalovirus retinitis (with loss of vision) 
9. Encephalopathy, HIV related 
10. Herpes simplex: chronic ulcers (>1 month's duration) or bronchitis, pneumonitis, or 
esophagitis (onset at age >1 month) 
11. Histoplasmosis, disseminated or extrapulmonary 
12. Isosporiasis, chronic intestinal (>1 month's duration) 
13. Kaposi sarcoma 
14. Lymphoid interstitial pneumonia 
15. Lymphoma, Burkitt (or equivalent term) 
16. Lymphoma, immunoblastic (or equivalent term) 
17. Lymphoma, primary, of brain 
18. Mycobacterium avium complex or Mycobacterium kansasii, disseminated or 
extrapulmonary 
19. Mycobacterium tuberculosis of any site, pulmonary, disseminated, or extrapulmonary 
20. Mycobacterium, other species or unidentified species, disseminated or extrapulmonary 
21. Pneumocystis jirovecii pneumonia 
22. Pneumonia, recurrent 
23. Progressive multifocal leukoencephalopathy 
24. Salmonella septicemia, recurrent 
25. Toxoplasmosis of brain, onset at age >1 month 
26. Wasting syndrome attributed to HIV” (CDC, 2008) 
 
Nucleic Acid Testing (NAT): “NAT refers to nucleic acid testing using extraction of nucleic acid 
from donor plasma followed by a step to amplify and detect viruses.  These tests are used to 
detect a number of viruses including: 
 NATB - NAT testing for the Hepatitis B virus 
 NATC–NAT testing for the Hepatitis C virus 
 NATH – NAT testing for the HIV virus 
 NATW – NAT testing for the West Nile Virus” (Blood Bank of Alaska, 2014) 
 
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI): “These are called "non-nukes." They 
work in a very similar way to "nukes." Non-nukes also block the enzyme, reverse transcriptase, 
and prevent HIV from making copies of its own DNA. But unlike the nukes (which work on the 
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genetic material), non-nukes act directly on the enzyme itself to prevent it from functioning 
correctly” (AIDS.gov, 2009). 
 
 
Nucleoside Reverse-Transcriptase Inhibitors (NRTI): “Sometimes called "nukes." These drugs 
work to block a very important step in HIV’s reproduction process. Nukes act as faulty building 
blocks in production of viral DNA production. This blocks HIV’s ability to use a special type of 
enzyme (reverse transcriptase) to correctly build new genetic material (DNA) that the virus 
needs to make copies of itself” (AIDS.gov, 2009). 
 
Protease Inhibitor (PI): “interfere with the HIV enzyme called protease, which normally cuts 
long chains of HIV proteins into smaller individual proteins. When protease does not work 
properly, new virus particles cannot be assembled” (National Institute of Allergy and Infectious 
Disease, 2013). 
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Appendix B 
HIV Questionnaire 
 
The purpose of this survey is to seek further information about knowledge and attitudes college 
students concerning HIV. 
 
1) The acronym HIV stands for: 
a) Human Immunoinsufficiency virus 
b) Host Immunocompromisation virus 
c) Human Immunodeficiency virus 
 
2) HIV is transmitted through all of the following EXCEPT: 
a) Blood 
b) Semen 
c) Breast Milk 
d) Saliva 
 
3) Once a person has been exposed to HIV, they will experience a stage of infection with little-
to-no symptoms, which lasts approximately: 
a) 1 year 
b) 3 years 
c) 10 years 
d) 15 years 
 
4) HIV is typically diagnosed through a(n): 
a) MRI 
b) X-Ray 
c) Oral fluid swab 
d) Lung biopsy 
 
5) According to the World Health Organization an estimated ____ people are HIV positive. 
a) 2 million 
b) 10 million 
c) 25 million 
d) 35 million 
 
6) What is the difference between HIV and AIDS? 
a) There is no difference, they are the same thing 
b) HIV causes AIDS 
c) AIDS only occurs to poor people 
 
7) HIV is treated with: 
a) Dialysis 
b) Combination drug therapy 
c) There is no treatment available 
d) Radiation 
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8) I believe that I am well educated about HIV. 
 
Strongly Disagree Disagree Agree  Strongly Agree 
 
9) Once exposed to HIV, there is nothing that can be done about it. 
 
Strongly Disagree Disagree Agree  Strongly Agree 
 
10) It is unlikely to contract HIV while in college. 
 
Strongly Disagree Disagree Agree  Strongly Agree 
 
11) I can tell if someone has HIV by looking at them. 
 
Strongly Disagree Disagree Agree  Strongly Agree 
 
12) There are enough HIV awareness programs on my college campus. 
 
Strongly Disagree Disagree Agree  Strongly Agree 
 
13) If a person is exposed to HIV on a Saturday, the virus can be transmitted by the following 
Saturday. 
 
Strongly Disagree Disagree Agree  Strongly Agree 
 
14) HIV affects people from all social, economic, and ethnic backgrounds. 
 
Strongly Disagree Disagree Agree  Strongly Agree 
 
15) HIV testing should be free and readily available to college students. 
 
Strongly Disagree Disagree Agree  Strongly Agree 
 
16) HIV positive individuals are to blame for their infection. 
 
Strongly Disagree Disagree Agree  Strongly Agree 
 
17) What is your age? 
a) 17-19 
b) 20-22 
c) 23-25 
 
18) What is your gender? 
a) Male  
b) Female 
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c) I choose not to answer 
19) What is your academic standing? 
a) Freshman 
b) Sophomore 
c) Junior  
d) Senior 
 
20) What is your ethnicity? 
a) Caucasian 
b) Asian 
c) African American 
d) Hispanic 
e) Native American/ Alaska Native 
f) Two or more ethnic backgrounds 
 
Thank you for your participation, your answers are important to the understanding of 
attitudes and knowledge of students about HIV. 
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Dear Volunteer, 
 
As a part of a study directed by Anita Ihuwan and Dr. Misty Rhoads in the department of Health 
Studies within the College of Education and Professional Services at EIU, further investigation is 
desired into the knowledge and attitudes of college students concerning HIV. Dr. Misty Rhoads 
and Anita Ihuwan wish to invite you to participate in this research study. The surveys will be 
anonymous with no identifying factors. Only the researcher will review the surveys, and solely 
for the purpose of coding data and performing analysis. 
 
Data will be kept on file for three years before being destroyed. The consent forms will be kept 
in a secure file separate from the data collected through these recordings. Only the primary 
researcher will have access to the master code key and consent forms as well as the data. 
 
Participation is voluntary. If you choose to participate in this research study, it will take you 
approximately 5 minutes. Please remember that your participation in this study is voluntary and 
you may withdrawal from the study at any time without penalty. You can contact Dr. Rhoads 
directly to request your withdrawal from the study, at mlrhoads@eiu.edu. 
 
All reports based on this research and written by the researcher will maintain the anonymity and 
confidentiality of the participants. Please retain this page for your personal records. If you 
volunteer to participate in this study, please sign and date the second page and return it to the 
researcher. 
 
If you have any questions concerning this study and its execution, please contact 
 
Dr. Misty Rhoads 
 
Lantz 1142 Eastern Illinois University 
 
Charleston, IL 61920 
 
via office telephone: 217-581-6203 
 
via email: mlrhoads@eiu.edu 
 
This project has been reviewed and approved by the EIU Human Subjects Committee. Questions 
concerning your rights as a participant in this research may be addressed to the Committee 
Chairperson, Office of Research Development and Administration, EIU, Charleston, IL 61920. 
Phone (217) 581-8576. 
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Knowledge and attitudes of college students concerning HIV 
 
_____ I agree to voluntarily participate in this activity and know my responses will be reported 
in the aggregate and kept confidential and anonymous. 
 
_____ I do not wish to participate in this study. 
 
 
_________________________                            ___________ 
Print Name     Date 
 
